Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis - 1 Jan 2000

Ibarretxe Daiana, Girona Josefa, Plana Núria, Cabré Anna, Ferré Raimón, Amigó Núria, Guaita Sandra, Mallol Roger, Heras Mercedes, Masana Luis

Abstract excerpt

BACKGROUND: PCSK9 is a pivotal molecule in the regulation of lipid metabolism. Previous studies have suggested that PCSK9 expression and its function in LDL receptor regulation could be altered in the context of diabetes. The aim was to assess PCSK9 plasma levels in patients with type 2 diabetes (T2DM) and other related metabolic disorders as well as its relation to the metabolomic profile generated by nuclear...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Cholesterol, LDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dyslipidemias

Share to Magnetic Resonance Spectroscopy

Share to Metabolic Diseases

Share to Metabolic Syndrome

Share to Metabolomics

Share to Proprotein Convertase 9

Source

Identifiers

PMID: 26743379
DOI: 10.1016/j.arteri.2015.11.001

Genes

PCSK9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.PMID 26743379Read ↗

Clinical aspects of PCSK9.Semantic proximity Read ↗

PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study.Semantic proximity Read ↗

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina.Semantic proximity Read ↗

PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes.Semantic proximity Read ↗

ANGPTL3 binds to PCSK9 to coordinately regulate intracellular lipid homeostasisSemantic proximity Read ↗

Common and Rare PCSK9 Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.Semantic proximity Read ↗

Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome.Semantic proximity Read ↗

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9.Semantic proximity Read ↗

What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.Semantic proximity Read ↗

Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control studySemantic proximity Read ↗

PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort.Semantic proximity Read ↗

Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.